Abstract: A grounding element assembly for grounding electric current from a rotating shaft to a bore of a housing including a grounding element including an annular electrically conductive material formed with a hole in a center and an annular electrically conductive metal mesh formed with a hole in a center and embedded within the annular electrically conductive material. An annular conductive metal case attached to an outer perimeter of the grounding element.

Abstract: The present disclosure generally pertains to methods of treating myocardial infarct involving administering a platelet anti-aggregate, a cysteine-aspartic protease inhibitor, and reperfusion therapy. In certain embodiments, the platelet anti-aggregate is at least one P2Y12 receptor antagonist or Glycoprotein IIb/IIIa inhibitor, the cysteine-aspartic protease inhibitor is selected from the group consisting of Caspase-1, 4, 5, 11 and 12 inhibitors, and reperfusion therapy is percutaneous coronary intervention. In certain embodiments, the at least one P2Y12 receptor antagonist is selected from the group consisting of cangrelor, ticagrelor, clopidogrel and prasugrel. The disclosed methods provide an improved cardioprotective effect against infarction when compared with the current standard of care.

Abstract: A torque converter, including: a cover arranged to receive torque; an impeller and a turbine. The impeller includes an impeller shell non-rotatably connected to the cover and a plurality of impeller blades. The impeller shell includes an interior surface, and defines a plurality of first indentations in the interior surface. Each impeller blade in the plurality of impeller blades including a first tab disposed in a respective first indentation. The turbine is in fluid communication with the impeller and includes a turbine shell and turbine blades fixedly connected to the turbine shell. The first tab is fixedly secured to the impeller shell by a respective first portion of a material forming the impeller shell; or a respective first portion of a material forming the impeller shell contacts the first tab and overlaps the first tab in a first axial direction parallel to an axis of rotation of the torque converter.

Abstract: The present disclosure generally pertains to methods of treating myocardial infarct involving administering a platelet anti-aggregate, a cysteine-aspartic protease inhibitor, and reperfusion therapy. In certain embodiments, the platelet anti-aggregate is at least one P2Y12 receptor antagonist or Glycoprotein IIb/IIIa inhibitor, the cysteine-aspartic protease inhibitor is selected from the group consisting of Caspase-1, 4, 5, 11 and 12 inhibitors, and reperfusion therapy is percutaneous coronary intervention. In certain embodiments, the at least one P2Y12 receptor antagonist is selected from the group consisting of cangrelor, ticagrelor, clopidogrel and prasugrel. The disclosed methods provide an improved cardioprotective effect against infarction when compared with the current standard of care.